Economy of Germany

Sartorius strengthens product portfolio for cell and gene therapies by acquiring a majority stake in CellGenix

Retrieved on: 
Friday, July 2, 2021

GTTINGEN, Germany, July 2, 2021 /PRNewswire/ -- The life science group Sartorius, through its subgroup Sartorius Stedim Biotech, has acquired a majority stake in the reagent manufacturer CellGenix GmbH.

Key Points: 
  • GTTINGEN, Germany, July 2, 2021 /PRNewswire/ -- The life science group Sartorius, through its subgroup Sartorius Stedim Biotech, has acquired a majority stake in the reagent manufacturer CellGenix GmbH.
  • Sartorius has initially acquired 51 percent of this company, which has been privately owned until now, for around 100millioneuros in cash.
  • At the beginning of 2023 and 2026, Sartorius plans to acquire the remaining shares of CellGenix.
  • The Bioprocess Solutions Division with its broad product portfolio focusing on single-use solutions helps customers to manufacture biotech medications and vaccines safely and efficiently.

DGAP-News: GRENKE AG: GRENKE New Business Q2 2021: Return to Conclusion of More Contracts - First Indications of a Normalisation

Retrieved on: 
Friday, July 2, 2021

GRENKE AG: GRENKE New Business Q2 2021: Return to Conclusion of More Contracts - First Indications of a Normalisation

Key Points: 
  • GRENKE AG: GRENKE New Business Q2 2021: Return to Conclusion of More Contracts - First Indications of a Normalisation
    The issuer is solely responsible for the content of this announcement.
  • At the beginning of Q2 2020, new business in Germany was still less affected by the pandemic.
  • In comparison to this relatively robust performance a year ago, the DACH region saw lower year-on-year new leasing business in Q2 2021 of EUR 111.1 million (Q2 2020: EUR 131.6 million).
  • GRENKE concluded a total of 56,078 new lease contracts in the reporting period, corresponding to a conversion rate of 48%.

DGAP-News: Brockhaus Capital Management AG: Invitation to the virtual Brockhaus Technology Day

Retrieved on: 
Wednesday, June 30, 2021

Brockhaus Capital Management AG (BKHT, ISIN: DE000A2GSU42, "BCM"), a long-term oriented technology group focused on acquiring high-margin and high-growth technology champions within the German Mittelstand, invites to the Brockhaus Technology Day.

Key Points: 
  • Brockhaus Capital Management AG (BKHT, ISIN: DE000A2GSU42, "BCM"), a long-term oriented technology group focused on acquiring high-margin and high-growth technology champions within the German Mittelstand, invites to the Brockhaus Technology Day.
  • Brockhaus Capital Management AG (BKHT, ISIN: DE000A2GSU42, "BCM"), based in Frankfurt/Main, is a technology group acquiring high-margin and high-growth technology champions with B2B business models in the German Mittelstand.
  • With a unique platform approach and a long-term horizon, BCM actively and strategically supports its subsidiaries in achieving long-term profitable growth beyond industry and country boundaries.
  • At the same time, BCM offers a gateway into these non-listed German technology champions, which are otherwise inaccessible to capital market investors.

BASF offers unique apprenticeship program for its future talents

Retrieved on: 
Wednesday, June 30, 2021

The program offers apprentices a unique opportunity to gain on-the-job-training and earn industry recognized credentials while receiving a full-time wage.

Key Points: 
  • The program offers apprentices a unique opportunity to gain on-the-job-training and earn industry recognized credentials while receiving a full-time wage.
  • BASF has a strong need for a skilled and diverse workforce, and this program is an investment in our future team.
  • This year, BASF has launched apprenticeship programs at its sites in Freeport, Texas; Seneca and Converse, South Carolina; and Wyandotte, Michigan.
  • In addition to paying a competitive wage, BASF offers benefits and covers costs associated with the academic program.

DGAP-News: fox e-mobility AG publishes annual report for 2020 business year

Retrieved on: 
Wednesday, June 30, 2021

The financial year covers the period from January 1, 2020 to December 31, 2020 for the two group companies Fox Automotive Switzerland AG and Catinum AG.

Key Points: 
  • The financial year covers the period from January 1, 2020 to December 31, 2020 for the two group companies Fox Automotive Switzerland AG and Catinum AG.
  • On December 7th last year, the new group, fox e-mobility AG, was created through the contribution of Fox Automotive Switzerland AG to Catinum AG.
  • In the course of this so-called 'reverse merger', the stock exchange listing of fox e-mobility AG was also implemented on December 22, 2020.
  • However, fox e-mobility AG did not yet have any revenue in the 2020 financial year.

DGAP-News: GRENKE AG: Changes in the Supervisory Board of GRENKE AG and new member of the Board of Directors at GRENKE BANK

Retrieved on: 
Tuesday, June 29, 2021

As announced, founder Wolfgang Grenke will leave the Supervisory Board at the end of the upcoming Annual General Meeting on July 29 of this year.

Key Points: 
  • As announced, founder Wolfgang Grenke will leave the Supervisory Board at the end of the upcoming Annual General Meeting on July 29 of this year.
  • Claudia Krcmar and Florian Schulte have also declared that they will resign from the Supervisory Board at their own request with effect from the end of the upcoming Annual General Meeting.
  • In addition, Andreas Schulz (59), member of the GRENKE BANK AG Board of Directors responsible for the Market business unit, will leave the Company on August 1 of this year.
  • GRENKE BANK AG is a wholly owned subsidiary of GRENKE AG and, based on its portfolio, forms an important component of the Consolidated Group's strategy.

Aragen Announces Expansion of Discovery Research Agreement with Boehringer Ingelheim

Retrieved on: 
Tuesday, June 29, 2021

Aragen Life Sciences (formerly GVK BIO), a leading Contract Research and Development Organization, headquartered out of Hyderabad, India, announces an expansion of their discovery research agreement with Boehringer Ingelheim, with the goal of accelerating the discovery pipeline of Boehringer Ingelheim.

Key Points: 
  • Aragen Life Sciences (formerly GVK BIO), a leading Contract Research and Development Organization, headquartered out of Hyderabad, India, announces an expansion of their discovery research agreement with Boehringer Ingelheim, with the goal of accelerating the discovery pipeline of Boehringer Ingelheim.
  • This preferred partnership allows Boehringer Ingelheim, a leading research driven pharmaceutical company, to incorporate several design elements, synthesize, profile, and then characterize a wide range of chemotypes against key targets of interest in swift optimization cycles.
  • It has been our privilege to collaborate with the scientists at Boehringer Ingelheim, and we thank them for their trust and confidence in the Aragen team.
  • Aragen Life Sciences Pvt Ltd (Aragen) is a global leader in providing discovery, development and manufacturing solutions for life sciences firms.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Volkswagen Aktiengesellschaft – VLKAY; VLKPY

Retrieved on: 
Monday, June 28, 2021

NEW YORK, June 28, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Volkswagen Aktiengesellschaft (Volkswagen or the Company) (OTCMKTS: VLKAY; VLKPY).

Key Points: 
  • NEW YORK, June 28, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Volkswagen Aktiengesellschaft (Volkswagen or the Company) (OTCMKTS: VLKAY; VLKPY).
  • The investigation concerns whether Volkswagen and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • On March 31, 2021, further reports regarding how Volkswagen, Volkswagen of America, and its spokespeople purposefully misled reporters were published.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions.

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Volkswagen AG (VWAGY)

Retrieved on: 
Friday, June 25, 2021

On March 29, 2021, Volkswagen published a draft press release announcing its American subsidiaries supposed name change to Voltswagen.

Key Points: 
  • On March 29, 2021, Volkswagen published a draft press release announcing its American subsidiaries supposed name change to Voltswagen.
  • Media outlets reported that they confirmed with the Company that the name change was real.
  • On this news, Volkswagen AGs share price fell more than 5% over the next two trading days, thereby injuring investors.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Volkswagen AG (VWAGY)

Retrieved on: 
Wednesday, June 23, 2021

On March 29, 2021, Volkswagen published a draft press release announcing its American subsidiaries supposed name change to Voltswagen.

Key Points: 
  • On March 29, 2021, Volkswagen published a draft press release announcing its American subsidiaries supposed name change to Voltswagen.
  • On this news, Volkswagen AGs share price fell more than 5% over the next two trading days, thereby injuring investors.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles